Fosinopril in Acute Myocardial Infarction Study - FAMIS

Description:

The FAMIS trial was a prospective, multicenter, randomized, double-blind, placebo-controlled trial designed to assess the clinical and hemodynamic effects of the angiotensin-converting enzyme (ACE) inhibitor fosinopril in selected patients with anterior acute myocardial infarction (AMI) who received fibrinolytic therapy.